Diluted EPS came in at $-0.89, missed the $-0.79 consensus by $0.10.
Trailing eight quarters through Q4 2024
Common questions about Solid Biosciences Inc.'s Q4 2024 earnings report.
Solid Biosciences Inc. (SLDB) reported Q4 2024 earnings on March 6, 2025 before market open.
Solid Biosciences Inc. reported diluted EPS of $-0.89 for Q4 2024.
EPS missed the consensus estimate of $-0.79 by $0.10.
You can read the 10-K periodic report (0000950170-25-034644) directly on SEC EDGAR. The filing index links above go to sec.gov.